Search Results - "Kison, Paul V."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study by Raylman, R R, Kison, P V, Wahl, R L

    Published in European journal of nuclear medicine (01-01-1999)
    “…The capabilities and limitations of two-(2D) and three-dimensional (3D) fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) in detecting…”
    Get full text
    Journal Article
  2. 2

    Evaluation of FDG PET in Patients with Cervical Cancer by Sugawara, Yoshifumi, Eisbruch, Avraham, Kosuda, Shigeru, Recker, Betty E, Kison, Paul V, Wahl, Richard L

    Published in The Journal of nuclear medicine (1978) (01-07-1999)
    “…Although many human cancers can be imaged by 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) and PET, there is little clinical experience with FDG PET in cervical…”
    Get full text
    Journal Article
  3. 3

    Glucose Transporters and FDG Uptake in Untreated Primary Human Non-Small Cell Lung Cancer by Brown, Raya S, Leung, Jennifer Y, Kison, Paul V, Zasadny, Kenneth R, Flint, Andrew, Wahl, Richard L

    Published in The Journal of nuclear medicine (1978) (01-04-1999)
    “…PET imaging of malignant tumors with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) as a tracer is a noninvasive diagnostic and prognostic tool that measures…”
    Get full text
    Journal Article
  4. 4

    Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment by Kosuda, S, Fisher, S, Kison, P V, Wahl, R L, Grossman, H B

    Published in Annals of nuclear medicine (01-09-1997)
    “…Our retrospective PET and animal studies were conducted on a total of eight patients with normal testes and five male Sprague-Dawley rats. All the rats were…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results by Sugawara, Y, Braun, D K, Kison, P V, Russo, J E, Zasadny, K R, Wahl, R L

    Published in European journal of nuclear medicine (01-09-1998)
    “…The purpose of this study was to evaluate the feasibility of 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) and positron emission tomography (PET) for rapid…”
    Get full text
    Journal Article
  7. 7

    Splenic Fluorodeoxyglucose Uptake Increased by Granulocyte Colony-Stimulating Factor Therapy: PET Imaging Results by Sugawara, Yoshifumi, Zasadny, Kenneth R, Kison, Paul V, Baker, Laurence H, Wahl, Richard L

    Published in The Journal of nuclear medicine (1978) (01-09-1999)
    “…Using PET, we investigated the change in 18F-fluorordeoxyglucose (FDG) uptake in the spleen after granulocyte colony-stimulating factor (G-CSF) treatment…”
    Get full text
    Journal Article
  8. 8

    Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner by Shreve, P D, Steventon, R S, Deters, E C, Kison, P V, Gross, M D, Wahl, R L

    Published in Radiology (01-05-1998)
    “…To compare the performance of a dual-head single photon emission computed tomographic (SPECT) Anger camera operated in coincidence mode with that of a…”
    Get more information
    Journal Article
  9. 9

    Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer by Kosuda, S, Kison, P V, Greenough, R, Grossman, H B, Wahl, R L

    Published in European journal of nuclear medicine (01-06-1997)
    “…The purpose of this study was to assess the feasibility of imaging of bladder cancer with fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET)…”
    Get full text
    Journal Article
  10. 10

    Metabolic response of non-Hodgkin's lymphoma to 131-I-Anti-B1 radioimmunotherapy: Evaluation with FDG PET by Torizuka, Tatsuo, Zasadny, Kenneth R, Kison, Paul V, Rommelfanger, Stephen G

    Published in The Journal of nuclear medicine (1978) (01-06-2000)
    “…131I-anti-B1 (CD20) radioimmunotherapy (RIT) is a promising approach for treatment of non-Hodgkin's lymphoma (NHL). We assessed the tumor metabolic response to…”
    Get full text
    Journal Article
  11. 11

    Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans by Zasadny, K R, Kison, P V, Quint, L E, Wahl, R L

    Published in Radiology (01-12-1996)
    “…The authors quantitatively evaluated possible distortions of tumor size and shape introduced on non-attenuation-corrected…”
    Get more information
    Journal Article
  12. 12

    Metabolic Response of Non-Hodgkin's Lymphoma to 131I-Anti-B1 Radioimmunotherapy: Evaluation with FDG PET by Torizuka, Tatsuo, Zasadny, Kenneth R, Kison, Paul V, Rommelfanger, Stephen G, Kaminski, Mark S, Wahl, Richard L

    Published in The Journal of nuclear medicine (1978) (01-06-2000)
    “…131I-anti-B1 (CD20) radioimmunotherapy (RIT) is a promising approach for treatment of non-Hodgkin's lymphoma (NHL). We assessed the tumor metabolic response to…”
    Get full text
    Journal Article
  13. 13